Xcelience Expands Xcelodose® Services To Enable Preliminary Compound Evaluation In The Experimental Area

Tampa, FL (October 8, 2009) – Xcelience, a leader in early development services, recognizes that providing access to a third, dedicated Xcelodose® 120 precision powder micro-dosing system in the experimental area enables clients to accelerate drug development with earlier go/ no-go decisions and flexible options for experimental studies.

“Xcelience has always been committed to helping clients work smarter,” says Derek Hennecke, CEO and President. “We were the first to bring Xcelodose® technology to North America, and now it’s the industry standard. To date we have manufactured over 100 clinical supply batches using Capsugel’s Xcelodose® precision powder micro-dosing systems. Now we want to deliver the same high-quality results in the experimental area.”

API into Capsule and powder-in-bottle (PIB) services are designed to accelerate drug development without sacrificing quality, cost or precious material. In some specific cases we have been able to shave as much as 17 weeks from traditional development timelines. By dedicating our existing Xcelodose® 600 and 600S systems to clinical supply manufacturing, and dedicating an Xcelodose® 120S to experimental studies, we can guarantee the same high-quality results that we have been delivering for years.

Xcelience LLC, is a contract research organization which has been providing formulation development, preformulation, analytical, and clinical trial manufacturing since 1997. The company has a solid reputation for accelerating early development activities to speed potential drugs to clinical trials while applying stage-specific scientific knowledge and experience. Xcelience's unique corporate structure creates project teams that work intensively with each client, bringing an extension of their own organization into the Xcelience lab.

About Xcelience: Keep on top of new developments in Xcelience and throughout the drug development industry by following us on Twitter www.twitter.com/Xcelience. For more detailed information about Xcelience, visit www.xcelience.com.